Molecular Diagnosis and Therapy Market, Global Outlook and Forecast 2023-2028

Report ID: 1546441 | Published Date: Oct 2024 | No. of Page: 68 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
This report contains market size and forecasts of Molecular Diagnosis and Therapy in Global, including the following market information:
Global Molecular Diagnosis and Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Diagnosis and Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis and Therapy include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis and Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Type, 2021 (%)
PCR
DNA Sequencing
NGS
Global Molecular Diagnosis and Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, by Application, 2021 (%)
Diagnostic Laboratories
Research & Academic Laboratories
Global Molecular Diagnosis and Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Molecular Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnosis and Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Diagnosis and Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific

Frequently Asked Questions
Molecular Diagnosis and Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Diagnosis and Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Diagnosis and Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports